Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration ; volume:20 ; number:03 ; year:2010 ; pages:188-191
The Indian journal of radiology and imaging ; 20, Heft 03 (2010), 188-191
- Beteiligte Personen und Organisationen
-
Parashari, Umesh C.
Aga, Pallavi
Parihar, Anit
Singh, Ragini
Joshi, Vindhya
- DOI
-
10.4103/0971-3026.69353
- URN
-
urn:nbn:de:101:1-2021090211251130120622
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Parashari, Umesh C.
- Aga, Pallavi
- Parihar, Anit
- Singh, Ragini
- Joshi, Vindhya
Ähnliche Objekte (12)
A therapeutic approach to pantothenate kinase associated neurodegeneration
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Mitochondria-associated membranes as hubs for neurodegeneration
cGAS-STING triggers inflammaging-associated neurodegeneration
Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Mitochondria-associated membranes as hubs for neurodegeneration
cGAS-STING triggers inflammaging-associated neurodegeneration
Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Mitochondria-associated membranes as hubs for neurodegeneration
cGAS-STING triggers inflammaging-associated neurodegeneration